MAP1LC3B and colorectal carcinoma: Consistently, 3-MA treatment remarkably attenuated VP-PDT-induced autophagy, as evidenced by a decreased autophagic MAP1LC3B-II/MAP1LC3B-I ratio and increased expression of SQSTM1/p62 in CRC cells (Fig. 3C, F).